Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Lexeo Therapeutics, Inc. (LXEO) had Non-Operating Income/Expense of $2.15M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-25.87M |
|
-- |
|
-- |
|
$28.02M |
|
$-28.02M |
|
|
Non-Operating Income/Expense |
$2.15M |
$-25.87M |
|
$-25.87M |
|
$-25.87M |
|
$-25.87M |
|
$-25.87M |
|
$-25.87M |
|
$-28.02M |
|
$-27.93M |
|
85.63M |
|
85.63M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$217.91M |
|
$1.12M |
|
$36.99M |
|
$254.90M |
|
$15.69M |
|
$0.10M |
|
$4.14M |
|
$19.84M |
|
$235.06M |
|
$235.06M |
|
$235.06M |
|
78.62M |
|
| Cash Flow Statement Financials | |
$-38.74M |
|
$41.72M |
|
$26.85M |
|
$66.25M |
|
$96.08M |
|
$29.83M |
|
$8.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.89 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-38.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.00% |
|
-11.00% |
|
-10.15% |
|
-11.00% |
|
$2.99 |
|
$-0.45 |
|
$-0.45 |
|